Purpose of review Advances in technology coupled with increased penetration of mobile phones and smart devices are rapidly changing healthcare delivery. Mobile phone applications ('apps'), text messages, and Internet platforms used alone or in combination are now providing interventions targeting people with multiple cardiovascular risk factors. The present article will review the emerging evidence regarding apps and discuss their potential role in providing secondary prevention interventions via mobile phones.
INTRODUCTION
Cardiac rehabilitation and secondary prevention programmes are recommended in international guidelines for those recovering from a cardiac event [1] and have been demonstrated to reduce morbidity and mortality from CVD [2] . Such programmes aim to reduce multiple cardiovascular disease (CVD) risk factors, and ensure the uptake of cardioprotective medications. They are typically delivered in an outpatient setting, with group-based exercise, and are time-limited [3] . Globally, reported participation rates are low, with the majority of cardiac event survivors failing to meet key CVD risk reduction targets [4] . Many barriers exist to referral, uptake, and completion, and have been widely documented [5] . Distance, timing of programmes, and unwillingness to participate in a group, are frequently cited as barriers to participation [5] . With the rapid increase in mobile phone ownership, mobile phone enabled programmes are suggested as one way to address these barriers.
Mobile applications or 'apps' are computer programs that operate on a smartphone, tablet, or other mobile device. They have a wide range of intended uses, from service provision (e.g. banking and travel services), to social media and games. Mobile apps have become so commonplace in cardiovascular health that both the European Society of Cardiology and the American Heart Association have recently released position papers on their use [6, 7] . Both organizations comment on the great potential of mobile apps to transform cardiovascular health, but urge caution about the quality of widely available apps; this is not surprising, given their rapid development. From June 2015 to January 2017, the number of available apps in Apple's app store alone rose from 1.5 to 2.2 million [8] . The largest app store, Google Play, has over 2.5 million available apps [9] .
Research involving apps has been considerably slower to evolve; the majority of trials typically test a mobile phone-based intervention aimed at improving a single risk factor, for example overweight. However, there is emerging evidence that mobile apps can successfully address multiple CVD risk factors among those with CVD. Overall, seven studies have published the results of randomized controlled trials (RCT) of mobile phone apps which demonstrated multiple CVD risk factor reduction (Table 1) 
STUDIES DELIVERING INTERVENTIONS VIA MOBILE PHONE
The simplest mobile phone-based interventions are text messages. Although several studies have used text messages as part of an intervention, only one study, the Tobacco, Exercise and Diet Messages RCT (TEXT-ME) has investigated text messaging without other components (e.g. a supportive website) [11 && ]. This single-blind, parallel group study recruited 710 participants following a myocardial infarction, or who had angiographically confirmed coronary heart disease. The participants were mostly male (82%), and mean age was 58 AE 9.2 years. Both groups participated in usual care, which included community follow up, and the majority were referred to cardiac rehabilitation. In addition, those in the intervention group (n ¼ 352) received text messages four times a week for six months. The messages had been developed and tested to give simple, positive healthy information around key CVD risk reduction behaviours and medication adherence [16] . The messages were automated and tailored to the
KEY POINTS
There is emerging evidence that mobile phones interventions improve CVD risk factors.
It is hard to determine the 'active ingredient' of mobile apps.
The long-term benefit of m-health is unknown individuals' baseline characteristics; for example, nonsmokers did not receive smoking cessation messages. The programme was not interactive. At 6 months, the primary endpoint of low density lipoprotein was 76 mg/dl in the intervention group, compared to 84 mg/dl in the usual care group, a mean difference of 8 mg/dl, which was statistically significant (P ¼ 0.04). Importantly, there were additional improvements in multiple CV risk factors in the intervention group. There were some interesting observations regarding the study derived from a qualitative evaluation. First, although all participants were advised that the system was automated and one-directional, 403 text messages were received by the investigators from 116 unique mobile phone numbers [17 & ]. It also appeared that when participants received the text messages they imagined that the research assistant who had recruited them was sending the messages personally. Importantly, the majority of the participants found the intervention acceptable, and many would have liked the intervention to continue past the six months of the study [17 & ]. The other six studies used a combination of an Internet platform and either text messages, biometric monitoring, or a mobile app. Using multiple elements makes it challenging to identify which of the elements are the primary driver of behaviour change. The study by Blasco et al. [10] was a singleblind RCT of 203 acute coronary syndrome survivors. Both groups received lifestyle counselling and the usual care of their treating physician. Those in the intervention group uploaded their weight, heart rate, blood pressure, lipids and glucose via their mobile phone, which were sent to a web interface. A cardiologist reviewed the data in the web interface, and made tailored recommendations, which were sent to the patients by text message. At 12 months, the intervention group, compared to the control group, had better achievement of treatment goals for blood pressure (62.1 vs. 42.9%, P ¼ 0.012), and glycated haemoglobin A 1c (86.4 vs. 54.2%, P ¼ 0.018). They also had lower body mass index (À0.77 vs þ0.29 kg/m 2 ), P ¼ 0.005). However, there were no differences in low density lipoprotein levels or rates of smoking cessation [10] .
Finnish investigators evaluated a programme that involved a monitoring health professional, delivering an intervention via a mobile phone [18] . This study randomized 267 participants with coronary heart disease, and 250 participants with diabetes to a self-monitoring intervention, in which the participants were asked to upload blood glucose, blood pressure, weight, and a daily step count to a mobile phone-which then automatically transferred the data to the patient's personal health record. The health professional then called the participant on the mobile phone every 4-6 weeks to discuss the information that had been uploaded. The primary endpoint of the study was health related quality of life, however no difference in outcome was observed in either group. There were observed differences in the waist circumference between the coronary heart disease groups, and the diabetes groups, which led the authors to conclude that the intervention may be of more benefit to those with diabetes [18] . However, although the intervention is described as a mobile phone intervention and appears to include text messaging, the text messages went to the healthcare professional, so the primary potential for the intervention to promote behaviour change was really through 4-6 weekly telephone calls.
The SUPPORT study [12] focused on increasing adherence to an antiplatelet drug, but also aimed to influence multiple cardiovascular risk factors in 174 individuals after a myocardial infarction. Both intervention and control groups received cardiac rehabilitation, as per the Swedish national standard. Both groups were provided: with a drug adherence diary app on their smartphone allowing the participants to record their intake of an antiplatelet drug; and, both groups were sent a text message reminder if they did not record taking the drug within the prescribed timeframe. In addition, the intervention group received educational messages, tailored to their individual circumstances. The intervention group could access four educational modules addressing extended drug adherence, exercise, weight management and smoking cessation. An automated feedback logic was developed to ensure that messages were tailored, but the data that patients recorded was not monitored. When a message was generated in the app, a text message was also sent to alert the participant. At 6 months, the intervention group demonstrated greater medication adherence, compared to the control group (nonadherence score 16.6 vs 22.8, P ¼ 0.025) [12] .
The Heart Exercise And Remote Technologies (HEART) study [15] involved a personalized, automated package of text messages and access to a secure internet site. This site included video messages aimed at increasing exercise behaviour, delivered over 24 weeks. Participants with coronary heart disease (n ¼ 171) were randomised to usual care, or the HEART intervention. The primary outcome was peak oxygen uptake (PVO 2 ). At 24 weeks there were no differences in PVO 2 between the two groups (difference À0.21 ml/kg/min; 95% CI, À1.1-0.7; P ¼ 0.65). However, there were significant improvements in outcomes, including leisure time physical activity (difference 110.2 min/week; 95% CI, À0.8-221.3; P ¼ 0.05) and walking (difference 151.4 min/week; 95% CI, 27.6-275.2; P ¼ 0.02).
Similarly, The Text4Heart study [13] , which was conducted by the same investigators as the HEART study, also included daily text messages and a supporting website over a 24-week period. The messages were fully automated and underpinned by social cognitive theory. The trial included 123 participants with coronary heart disease, randomised to usual care, or the intervention group. The primary outcome was adherence to healthy lifestyle behaviours measured using a self-reported composite health behaviour score (!3) at 3 and 6 months. A significant treatment effect in favour of the intervention was observed for the primary outcome at 3 months (AOR 2.55; 95% CI, 1.12-5.84; P ¼ 0.03), but not at 6 months (AOR 1.93; 95% CI, 0.83-4.53; P ¼ 0.13). Of note, 85% of people reported reading all the text messages they were sent, whereas visits to the supporting website varied from 0 to 100 per individual [13] .
The final study is the Care Assessment Platform [14] . This was a RCT of traditional cardiac rehabilitation compared to an intervention group using a smartphone cardiac rehabilitation app providing daily SMS messages, multimedia education topics, relaxation audio files and a light-to-moderate physical activity program. Participants were able to set and monitor goals and the app included a step counter and exercise diary. Trial results demonstrated that participation within cardiac rehabilitation was much higher in the intervention group. Importantly, the intervention group had significantly higher rate of adherence and completion than did the traditional cardiac rehabilitation group. Both the intervention group and traditional cardiac rehabilitation group significantly improved their 6-min walk test distance (537 AE 86 to 584 AE 99 m vs. 510 AE 77 to 570 AE 80 m), emotional state and quality of life; and lost nonsignificant amounts of weight. The study demonstrated a smartphone app can achieve equivalent improvements in secondary prevention outcomes as traditional cardiac rehabilitation, and importantly had significantly higher uptake (80 vs. 62%), adherence (94 vs. 68%) and completion (80 vs. 47%) rates than a traditional cardiac rehabilitation group (P < 0.05).
THE FUTURE OF SECONDARY PREVENTION VIA MOBILE PHONES
The complexity of these interventions makes identifying the active ingredient and appropriate dose challenging. Mixed methods study design, and process evaluations will help to improve understanding of what really matters. Even in the TEXT-ME study, in which the intervention appeared to be a simple one-directional text message, the qualitative component revealed that people tend to assign human characteristics to the intervention, believing that the automated messages were sent by the friendly research assistant who had recruited them [17 & ]. As technology evolves this understanding will become ever more important. Wearable trackers that monitor physical activity have been shown to provide valid and reliable information for people with coronary heart disease [19] . To extend this further, the 'Internet of Things' -where connected devices talk to each other to inform healthcare decisions -may become the secondary prevention tool of the future. An individual might have sensors at home or in the car that detect: changes in heart rate or breathing; subtle changes in skin colour that suggest need for a change in medication; or, a reminder to take medication. Common digital assistants such as Apple's Siri could be adapted for health purposes so that an algorithm prompts correct choices in health behaviours. Our biggest challenge as researchers and clinicians will be responding quickly enough to ensure that the evolving technologies are evidence-based and that we understand the benefits, or lack thereof, of the tools that are available.
CONCLUSION
Evidence in support of mobile-phone-delivered secondary prevention is emerging; of seven RCTs, six show improvements in cardiovascular risk factors, when compared to control. However, the diversity of the interventions makes it challenging to understand which ingredient matters most when it comes to recommending mobile phone interventions. In addition, long-term outcomes are currently unknown. As there are a multitude of apps currently available, it is also important that consumers are able to make informed choices. The evidence-base for the apps needs to be robust, credible, clear and unambiguous. Health-care bodies could regulate CVD apps or organisations such as heart foundations could provide endorsements for them., but the volume of available apps makes this challenging. It may be more feasible to provide consumers with tools to make informed decisions around choosing evidence-based apps that provide the best outcomes.
